Tickwind
TodayOpportunitiesMarketsAI Chat
EN
Log inSign up
Tickwind

Read every tick. See where the market's blowing.

  • X
  • TelegramChinese
  • Newsletter

Product

  • Markets
  • Theme Zones
  • All stocks
  • Compare
  • Hot stocks
  • Opportunities
  • News
  • Discussion
  • Watchlist
  • What's new

Account

  • Settings
  • Newsletter
  • For writers
  • MCP server
  • Contact
  • Log in
  • Sign up
MarketsTheme ZonesAll stocksCompareHot stocksOpportunitiesNewsDiscussionWatchlistWhat's newSettingsNewsletterFor writersMCP serverContactLog inSign up

© 2026 Tickwind. Not investment advice.

Made for the curious investor.

Home/KTTA/Net margin

PASITHEA THERAPEUTICS CORP. (KTTA) Net margin 2021–2022

PASITHEA THERAPEUTICS CORP. (KTTA) net profit margin by fiscal year — reported net income divided by reported revenue.

-2864.3%FY2022 · since FY2021: -14430.5% → -2864.3%
2122
Fiscal yearValueYoY
FY2022-2864.3%+11566.2 pp
FY2021-14430.5%—

Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.

Source: SEC XBRL filings · For reference only · Not investment advice

More KTTA financial trends

KTTA RevenueKTTA Net incomeKTTA Gross profitKTTA Gross marginKTTA Operating incomeKTTA Operating marginKTTA Operating cash flowKTTA Free cash flowKTTA Capital expendituresKTTA Return on equityKTTA Stock buybacksKTTA Dividends paidKTTA Total assetsKTTA Total liabilitiesKTTA Shareholders’ equityKTTA overview →